Literature DB >> 21443865

Association analysis of GSK3B and MAPT polymorphisms with Alzheimer's disease in Han Chinese.

Na Zhang1, Jin-Tai Yu, Ying Yang, Jing Yang, Wei Zhang, Lan Tan.   

Abstract

Aberrant phosphorylated tau is the major component of the neurofibrillary tangles in Alzheimer's disease (AD) brains. Glycogen synthase kinase-3beta (GSK-3B) phosphorylates tau protein, and increased GSK-3B expression has been associated with neurofibrillary tangles. To determine whether polymorphisms in the GSK3B gene and microtubule associated protein tau (MAPT) gene underpin susceptibility to late-onset Alzheimer's disease (LOAD), we conducted a case-control study in a Chinese cohort of 257 LOAD cases and 326 healthy controls matched for sex and age. The minor allele (T) of the promoter rs334558 within GSK3B was associated with an increased risk of LOAD (odds ratios/OR=1.381, P=0.006), T carriers may be easier to develop AD (P=0.002, power=0.92). And the association was influenced by the presence of ApoE ε4 allele. Moreover, it showed a highly significant synergistic interaction with the ApoE ε4 allele (OR=3.782, P<0.001). All subjects in this study were identified as H1 MAPT haplotype. Haplotype analysis revealed that, the -157T/-50T haplotype significantly increased the risk of developing AD (OR=1.383, P=0.013). Our findings suggest that the functional polymorphisms in GSK3B promoter may be involved in the risk of developing sporadic LOAD in Han Chinese.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21443865     DOI: 10.1016/j.brainres.2011.03.052

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  The association between single nucleotide polymorphisms of GSK 3β gene and sporadic Alzheimer's disease in a cohort of southern Chinese Han population.

Authors:  Jing Li; Fan Zeng; Juan Deng; Jie Zhu; Lin Li; Tao Zhang; Juan Liu; Li-Li Zhang; Chang-Yue Gao; Meng Zhang; Zhi-Qiang Xu; Hua-Dong Zhou; Yan-Jiang Wang
Journal:  Neurotox Res       Date:  2014-08-21       Impact factor: 3.911

Review 2.  The role of cholesterol metabolism in Alzheimer's disease.

Authors:  Jia-Hao Sun; Jin-Tai Yu; Lan Tan
Journal:  Mol Neurobiol       Date:  2014-05-18       Impact factor: 5.590

3.  The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease.

Authors:  Amy Gerrish; Giancarlo Russo; Alexander Richards; Valentina Moskvina; Dobril Ivanov; Denise Harold; Rebecca Sims; Richard Abraham; Paul Hollingworth; Jade Chapman; Marian Hamshere; Jaspreet Singh Pahwa; Kimberley Dowzell; Amy Williams; Nicola Jones; Charlene Thomas; Alexandra Stretton; Angharad R Morgan; Simon Lovestone; John Powell; Petroula Proitsi; Michelle K Lupton; Carol Brayne; David C Rubinsztein; Michael Gill; Brian Lawlor; Aoibhinn Lynch; Kevin Morgan; Kristelle S Brown; Peter A Passmore; David Craig; Bernadette McGuinness; Stephen Todd; Janet A Johnston; Clive Holmes; David Mann; A David Smith; Seth Love; Patrick G Kehoe; John Hardy; Simon Mead; Nick Fox; Martin Rossor; John Collinge; Wolfgang Maier; Frank Jessen; Heike Kölsch; Reinhard Heun; Britta Schürmann; Hendrik van den Bussche; Isabella Heuser; Johannes Kornhuber; Jens Wiltfang; Martin Dichgans; Lutz Frölich; Harald Hampel; Michael Hüll; Dan Rujescu; Alison M Goate; John S K Kauwe; Carlos Cruchaga; Petra Nowotny; John C Morris; Kevin Mayo; Gill Livingston; Nicholas J Bass; Hugh Gurling; Andrew McQuillin; Rhian Gwilliam; Panagiotis Deloukas; Gail Davies; Sarah E Harris; John M Starr; Ian J Deary; Ammar Al-Chalabi; Christopher E Shaw; Magda Tsolaki; Andrew B Singleton; Rita Guerreiro; Thomas W Mühleisen; Markus M Nöthen; Susanne Moebus; Karl-Heinz Jöckel; Norman Klopp; H-Erich Wichmann; Minerva M Carrasquillo; V Shane Pankratz; Steven G Younkin; Lesley Jones; Peter A Holmans; Michael C O'Donovan; Michael J Owen; Julie Williams
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

4.  GSK3B and MAPT polymorphisms are associated with grey matter and intracranial volume in healthy individuals.

Authors:  Carol Dobson-Stone; Patsie Polly; Mayuresh S Korgaonkar; Leanne M Williams; Evian Gordon; Peter R Schofield; Karen Mather; Nicola J Armstrong; Wei Wen; Perminder S Sachdev; John B J Kwok
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

5.  Glycogen synthase kinase 3: a point of integration in Alzheimer's disease and a therapeutic target?

Authors:  Siddhartha Mondragón-Rodríguez; George Perry; Xiongwei Zhu; Paula I Moreira; Sylvain Williams
Journal:  Int J Alzheimers Dis       Date:  2012-06-14

6.  An evidence-based approach to identify aging-related genes in Caenorhabditis elegans.

Authors:  Alison Callahan; Juan José Cifuentes; Michel Dumontier
Journal:  BMC Bioinformatics       Date:  2015-02-07       Impact factor: 3.169

Review 7.  The biological pathways of Alzheimer disease: a review.

Authors:  Marco Calabrò; Carmela Rinaldi; Giuseppe Santoro; Concetta Crisafulli
Journal:  AIMS Neurosci       Date:  2020-12-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.